Caris Life Sciences (CAI) Receivables - Net (2024 - 2025)
Caris Life Sciences has reported Receivables - Net over the past 2 years, most recently at $112.1 million for Q4 2025.
- Quarterly results put Receivables - Net at $112.1 million for Q4 2025, up 27.08% from a year ago — trailing twelve months through Dec 2025 was $112.1 million (up 27.08% YoY), and the annual figure for FY2025 was $112.1 million, up 27.08%.
- Receivables - Net for Q4 2025 was $112.1 million at Caris Life Sciences, up from $26.7 million in the prior quarter.
- Over the last five years, Receivables - Net for CAI hit a ceiling of $112.1 million in Q4 2025 and a floor of $26.7 million in Q3 2025.